Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
Clinical trial NCT02635776 · COMPLETED
Trial details
- NCT number
- NCT02635776
- Sponsor
- Aimmune Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-22
- Primary completion
- 2017-12-21
- Enrollment
- 555
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.